Oncology Central

Nanomedicine for the treatment of triple-negative breast cancer


Breast cancer is one of the leading causes of death. Breast cancer is generally classified based on the receptors overexpressed on the cell membrane, which include hormone receptors such as progesterone (PR) and estrogen (ER), and HER2. Triple-negative breast cancer (TNBC) is a type of cancer that lacks any of these three types of receptor proteins (ER/PR/HER2).

To view restricted content, please:

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.